BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update

Brainstorm Cell Therapeutics (BCLI) Misses Q1 EPS by 2c

May 16, 2022 7:07 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q1 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.

... More